Health Global News & Press Release Distribution

Health

All
APAC

Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication

SHANGHAI , July 18, 2023 /PRNewswire/ -- The product of Fosun Kite Biotechnology Co., Ltd., jointly established by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Kite Pharma ofthe United States (trade name: Yikaida®) for the treatment of adult large B-cell lymphoma (r/r LBCL) ("this new ind...

2023-07-19 10:42 1754

Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication

Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND

SHANGHAI, July 18, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 9MW2921 for advanced solid tumor was approved by the National Medical Products Administration (NMPA). 9MW2921 is dev...

2023-07-19 00:00 2644

Neurophet to unveil brain image analysis technology related to treatment of Alzheimer's disease at AAIC 2023

- New brain image analysis solution for Alzheimer's disease treatment is planned to be commercialized along with the release of treatment - In discussion with global big pharma companies for collaboration at AAIC SEOUL, South Korea, July 18, 2023 /PRNewswire/ -- Neurophet, an artificial in...

2023-07-18 21:00 2475

Neurophet to unveil brain image analysis technology related to treatment of Alzheimer's disease at AAIC 2023

Baird Medical Obtains NMPA Approval of Class III Registered Microwave Ablation Needle for Thyroid Nodules

GUANGZHOU, China, July 18, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, announced today that the Company's independently developed and produced disposable MWA ...

2023-07-18 20:30 1813

Duoning Biotech Acquires PreFluid to Strengthen Fluid Management Solutions

* PreFluid is a leader in integrated fluid solutions * PreFluid's peristaltic pumps are widely used in medical, pharmaceutical, chemical and environmental industries worldwide SHANGHAI, July 18, 2023 /PRNewswire/ -- Duoning Biotechnology Co., Ltd. ("Duoning Biotech") has used Shanghai Duoning...

2023-07-18 20:00 2241

Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

INCHEON, South Korea, July 18, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social and Governance (ESG) Report. The annual report outlines the company's progress toward its sustain...

2023-07-18 19:00 1792

2nd ZAODX World Conference on Early Detection of Cancer to Take Place in September 2023

GUANGZHOU, China, July 18, 2023 /PRNewswire/ -- The 2nd ZAODX World Conference on Early Detection of Cancer（EDOC-2）will take place on-site at the Huangpu International Conference Center,Guangzhou, China, and online in a virtual format from 15 to17 September, 2023. The conference aims to promote ...

2023-07-18 17:59 1321

2nd ZAODX World Conference on Early Detection of Cancer to Take Place in September 2023

Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis

* DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON™) platform facilitates extra-hepatic delivery of siRNA therapeutics * Acquisition includes DTx-1252 with the potential to deliver a transformative medicine to Charcot-Marie-Tooth Disease Type 1A (CMT1A) patients * Acquisitio...

2023-07-18 15:00 4940

SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech'

SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press conference SK Biopharmaceuticals mobilizes its cutting-edge modality platforms of radiopharmaceutical therapy (RPT), targeted protein degradation (TPD), and cell and gene therapy (CGT) aligning with its v...

2023-07-18 09:00 1588

Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

JIUQUAN, China, July 17, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), aChina-based pharmaceutical and chemical products manufacturer, received notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq"), datedJuly ...

2023-07-17 22:30 5122

BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program

* Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS * Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Acid Interference (RNAi) Nanomedicine (BTRiNTM) platform * BIORCHESTRA to receive in-kind products and services from Merck Group CAMBRIDGE, Mas...

2023-07-17 21:28 1934

GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development

SUZHOU, China, July 17, 2023 /PRNewswire/ -- On July 14, 2023, GeneQuantum, a leading pioneer committed to innovative bioconjugation technology, and InxMed, a clinical-stage biotechnology company dedicates on developing innovative therapies targeting drug resistance for hard-to-treat solid tumors...

2023-07-17 17:00 1446

Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio

CAMBRIDGE, Mass., July 13, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation and provider of integrated solutions from "Idea to IND" (I to ITM) announced that, DualityBio, a collaborator of Nona Bios...

2023-07-14 08:29 1817

Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, July 13, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2023-07-13 18:11 4055

Race executes agreement with Ardena for GMP manufacturing of RC220

* Race Oncology executes agreement with leading global contract development and manufacturing organisation, Ardena as additional partner for GMP manufacturing of flagship RC220 bistanrene formulation * Ardena has a long track record of providing sterile injectable products for all stages of c...

2023-07-12 19:30 2202

Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division

BOSTON, July 12, 2023 /PRNewswire/ -- Medicilon, a leading one-stop pharmaceutical preclinical R&D service platform CRO, recently appointed Dr.Liu Jian as the President of Drug Discovery Division. Medicilon recognizes the importance of drug discovery as the cornerstone of new drug innovation. Wit...

2023-07-12 18:46 2270

Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division

Bridge Biotherapeutics Joins PROLIFIC, the Prognostic Lung Fibrosis Consortium

Bridge to join as an industry member to advance the science of early detection and speed development of novel treatments SEONGNAM, South Korea and CAMBRIDGE, Mass., July 11, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel dru...

2023-07-12 06:00 1973

Doer Biologics Announces License Agreement with BioNTech

HANGZHOU, China, July 10, 2023 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announced that it has entered into a license agreement with BioNTech SE (Nasdaq...

2023-07-11 11:49 1873

AMAZFIT TEAMS UP WITH ULTRA-MARATHON LEGENED DEAN KARNAZES FOR THE LAUNCH OF AMAZFIT CHEETAH PRO

CUPERTINO, Calif., July 10, 2023 /PRNewswire/ -- Amazfit , a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), a health technology company, is excited to announce its collaboration with renowned ultra-marathoner and fitness icon,Dean Karnazes , as t...

2023-07-10 22:00 2259

Race executes global license agreement with City of Hope to access FTO IP

* Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations inthe United States. * Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene...

2023-07-10 19:30 1787

1 ... 74 75 767778 79 80 ... 273

Week's Top Stories

Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively

[Picked up by 274 media titles]

2024-09-19 08:00